| Repeat Intracerebroventricular Injections of RB-ADSC in Subjects Previously Treated in RBI Protocol RB-ADSC-02 (NCT07373067) | Regeneration Biomedical, Inc. | 2026-01-01 |
| EB-OC for the Treatment of Focal Chondral/Osteochondral Defects in the Knee (NCT06895889) | Epibone, Inc. | 2026-01-01 |
| Mesenchymal Stem Cells for Chronic Kidney Diseases (NCT07240987) | The First Affiliated Hospital of Air Force Medicial University | 2026-01-01 |
| Point-of-Care AI Assistance and Critical Care Outcomes: A Randomized Trial (NCT07293078) | MetroWest Artificial Intelligence Research Workgroup | 2026-01-01 |
| A Study of DC6001 Tablet in Healthy Chinese Adult Subjects (NCT07417566) | Heronova Pharmaceuticals | 2026-01-01 |
| Ultrasound-Guided Infraclvicular Block Using Dexmedetomidine Versus Nalbuphine as Adjuvants to Bupivacaine in Upper Limb Orthopedic Surgery (NCT07279727) | Assiut University | 2026-01-01 |
| Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT07216833) | Case Comprehensive Cancer Center | 2026-01-01 |
| Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study) (NCT07347197) | Heartseed Inc. | 2026-01-01 |
| JSKN016 in Combination With D-0502 for Locally Advanced or Metastatic HR-Positive, HER2-Negative Breast Cancer (NCT07336771) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2026-01-01 |
| Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG Trial (NCT07444398) | Khawaja Danish Ali | 2026-01-01 |
| National Collaborative Centre for Hepatic Regenerative Medicine (NC-CHRM): Phase I Study on Safety and Efficacy of Mesenchymal Stem-Cell (MSC) Therapy in Non-Viral Acute-on-Chronic Liver Failure (ACLF) (NCT07131540) | Institute of Liver and Biliary Sciences, India | 2026-01-01 |
| Targeted CD22/CD19 CAR-T Therapy for Consolidation in Standard-Risk B-ALL (NCT07575919) | Liping Dou | 2026-01-01 |
| Pilot Study: Miltefosine Gel (G-MTF) in Patients With Cutaneous Leishmaniasis (NCT07149753) | Universidad Industrial de Santander | 2026-01-01 |
| Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections (NCT07280598) | University of California, San Diego | 2025-12-31 |
| A Study to Evaluate the Food Effect on RNK08954 in Healthy Participants, and the Mass Balance Study of [14C]RNK08954 in Healthy Adult Male Subjects (NCT07334262) | Ranok Therapeutics (Hangzhou) Co., Ltd. | 2025-12-31 |
| Neoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers (NCT05296005) | Ohio State University Comprehensive Cancer Center | 2025-12-31 |
| Cardiac Perfusion and Metabolism With [11C] Acetate PET/CT is Associated With Hematopoietic System Activation in Acute Decompensated Heart Failure: An Imaging Sub-study (NCT03924102) | University of Alabama at Birmingham | 2025-12-31 |
| Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants (NCT07223671) | Bristol-Myers Squibb | 2025-12-31 |
| A Study of B2065 in Patients With Acute Ischemic Stroke (NCT07371624) | Tasly Pharmaceutical Group Co., Ltd | 2025-12-31 |
| A First-in-human, Single-ascending-dose Study of IBI3033 in Healthy Participants (NCT07311226) | Innovent Biologics (Suzhou) Co. Ltd. | 2025-12-31 |
| Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis (NCT07030283) | University of Colorado, Denver | 2025-12-31 |
| Study of ZGGS34 in Participants With Advanced Solid Tumors (NCT07258121) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2025-12-31 |
| An Umbrella Study of Recurrent, Extensive Stage Small Cell Lung Cancer Based on Molecular Typing (NCT07141771) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-12-31 |
| MicroRNA and MicroRNA Inhibitors Socket Study, Pilot Clinical Trial (NCT02579187) | Gustavo Avila-Ortiz DDS, MS, PhD | 2025-12-31 |
| A Study to Determine the Metabolism and Excretion of [14C]E2086 in Healthy Male Participants (NCT07308236) | Eisai Inc. | 2025-12-31 |
| The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (19#iSCLife®-HF) (NCT03180450) | Sclnow Biotechnology Co., Ltd. | 2025-12-31 |
| XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation (NCT05275374) | Xynomic Pharmaceuticals, Inc. | 2025-12-31 |
| Study of QLC5513 in Combination With Epalolimab Tovolimab (QL1706) ± Platinum in Patients With Advanced or Metastatic Malignant Solid Tumors (NCT07272590) | Qilu Pharmaceutical Co., Ltd. | 2025-12-30 |
| An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA) (NCT07392255) | Complement Therapeutics | 2025-12-30 |
| A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healthy Overweight/Obese Participants (NCT07230496) | Laekna Limited | 2025-12-30 |
| Role of Alpha-to-beta Cell Communication to Adapt Insulin Secretion to Insulin Resistance. (NCT07224334) | David D'Alessio, M.D. | 2025-12-30 |
| Phase I Clinical Trial of Enterovirus Type71 - Coxsackievirus Type A16 Bivalent Vaccine (NCT07326878) | Institute of Medical Biology, Chinese Academy of Medical Sciences | 2025-12-30 |
| Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC) (NCT06405230) | GlaxoSmithKline | 2025-12-30 |
| 68Ga-PSMA-0057 and 177Lu-PSMA-0057 in Patients With PSMA-Positive Metastatic Castration-Resistant Prostate Cancer (NCT07310355) | Chengdu StarRay Therapeutics Co., Ltd | 2025-12-30 |
| QTc Assessment in a Single-Dose Study of Hydronidone Capsules (NCT07263152) | Beijing Continent Pharmaceutical Co, Ltd. | 2025-12-30 |
| A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors (NCT07361562) | Cogent Biosciences, Inc. | 2025-12-30 |
| A Study in Healthy Men and Women to Test How BI 3000202 is Taken up and Processed by the Body (NCT07273474) | Boehringer Ingelheim | 2025-12-30 |
| Chinese Herbal Therapy (Qiqi Shengmai Formula) for Moyamoya Vasculopathy: The CHIMES Trial (NCT07286110) | Fudan University | 2025-12-30 |
| The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE (NCT07306585) | HC Biopharma Inc. | 2025-12-30 |
| A Phase l Clinical Study to Evalute the Safety,Tolerability,Pharmacokinetic Characteristics,and Preliminary Anti-tumor Efficacy of HJ-004-02 Tablets in Patients With Non-squamous Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutations (NCT07361237) | Tongji University | 2025-12-30 |
| Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface. (NCT06379685) | Laboratorios Sophia S.A de C.V. | 2025-12-30 |
| Tolerance of Local Administration of Cryopreserved Autologous Stromal Vascular Fraction Combined With Micrograft for the Treatment of Refractory Ano-perineal Fistulas in Crohn's Disease (NCT07629245) | Assistance Publique Hopitaux De Marseille | 2025-12-30 |
| An Early Phase Study of RT-114 (RaniPill Containing PG-102, a GLP-1/2 Dual Agonist) in Healthy Volunteers. (NCT06891287) | RANI Therapeutics | 2025-12-30 |
| A Study of Single and Multiple Doses of HRS-6257 in Healthy Subjects (NCT07301333) | Shanghai Hengrui Pharmaceutical Co., Ltd. | 2025-12-30 |
| A Study to Evaluate the Effect of Fasting Duration and Dulaglutide (LY2189265) Withholding on Gastric Retention in Participants With Type 2 Diabetes Mellitus (NCT07313813) | Eli Lilly and Company | 2025-12-29 |
| Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D (NCT07399678) | Alveus Therapeutics, Inc. | 2025-12-29 |
| Study of GVV858 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors (NCT07288359) | Novartis Pharmaceuticals | 2025-12-29 |
| Saci Nivo Rela for TNBC (NCT06963905) | Yale University | 2025-12-29 |
| Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults (NCT07176208) | Food and Drug Administration (FDA) | 2025-12-29 |
| A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039) (NCT07300280) | Merck Sharp & Dohme LLC | 2025-12-29 |
| Safety and Efficacy Trial of TV5M01 for Radiation-Induced Mucositis in Head and Neck Cancer Patients. (NCT06875791) | Fundacion Clinica Valle del Lili | 2025-12-28 |
| A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers (NCT07364877) | Daewon Pharmaceutical Co., Ltd. | 2025-12-28 |
| Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy (NCT07091370) | Juventas Cell Therapy Ltd. | 2025-12-27 |
| ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma (NCT07098364) | Fred Hutchinson Cancer Center | 2025-12-27 |
| A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult Volunteers (NCT07277712) | HK inno.N Corporation | 2025-12-27 |
| A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease (NCT07195825) | Shanghai Xinzhi BioMed Co., Ltd. | 2025-12-27 |
| Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients (NCT07266116) | Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | 2025-12-26 |
| Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer (NCT07298200) | Jia Wei | 2025-12-26 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ZX-8177 in Patients With Advanced Solid Tumors (NCT07310134) | Nanjing Zenshine Pharmaceuticals | 2025-12-26 |
| A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias (NCT05521087) | Janssen Research & Development, LLC | 2025-12-26 |
| A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure (NCT07265349) | Tasly Pharmaceutical Group Co., Ltd | 2025-12-26 |
| GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma (NCT07138547) | Chinese PLA General Hospital | 2025-12-26 |
| A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis. (NCT07318675) | Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. | 2025-12-25 |
| A Trial of Hydroxynidone Capsules in Single-dose Administration for Patients With Renal Insufficiency (NCT07262333) | Beijing Continent Pharmaceutical Co, Ltd. | 2025-12-25 |
| A Pharmacokinetic Study of VCT220 With Moderate Renal Impairment Patients (NCT07347808) | Vincentage Pharma Co., Ltd | 2025-12-25 |
| Optimal Dose of Zanubrutinib to Treat Adult Immune Thrombocytopenia (NCT07315373) | Peking University People's Hospital | 2025-12-25 |
| A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia (NCT07287930) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2025-12-25 |
| Prospective Randomized Controlled Clinical Study of Acupoint Application With Gutong Plaster in the Treatment of Moderate to Severe Cancer Pain (NCT07657390) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-12-25 |
| Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet (NCT07251712) | Galmed Pharmaceuticals Ltd | 2025-12-25 |
| Spinal Analgesia in Labour Pain (NCT07332130) | Minia University Hospital | 2025-12-24 |
| A Phase II Clinical Study Evaluating the Effectiveness of Injectable NC527-X in Intraoperative Imaging for Patients With Solid Tumors (NCT07538648) | Zhejiang Cancer Hospital | 2025-12-24 |
| A Study of MR001 Combined With Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) After First-line Therapy (NCT07235202) | Shenzhen Majory Biotechnology Co., Ltd. | 2025-12-24 |
| Bioequivalence Study of BGM0504 Injection (NCT07382908) | BrightGene Bio-Medical Technology Co., Ltd. | 2025-12-23 |
| Extracellular Vesicles for the Treatment of Syringomyelia (NCT07295067) | Xuanwu Hospital, Beijing | 2025-12-23 |
| A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2061 (NCT07241910) | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 2025-12-23 |
| A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants. (NCT07283263) | Bristol-Myers Squibb | 2025-12-23 |
| A Study to Evaluate Adrixetinib (Q702) in Adults With Active Chronic Graft-Versus-Host Disease (NCT07138196) | Qurient Co., Ltd. | 2025-12-23 |
| A Clinical Study of SHR-A1811(sc) Subcutaneous Injection in Patients With Solid Tumor (NCT07275242) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2025-12-23 |
| Safety and Efficacy of Paclitaxel Liposome Arterial Infusion Combined With Systemic Therapy for Second-Line Treatment of Advanced Liver Cancer (NCT07282509) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2025-12-23 |
| A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors (NCT07318805) | Pfizer | 2025-12-23 |
| Study of TN-001 Topical Eyedrops for Keratoconus (NCT07388069) | TheiaNova Ltd. | 2025-12-23 |
| A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment (NCT07231029) | Taisho Pharmaceutical Co., Ltd. | 2025-12-23 |
| First-In-Human (FIH), Single Ascending Dose (SAD) Study and Multiple Ascending Dose (MAD) Study of SP-101 Injection (NCT07334249) | Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd. | 2025-12-23 |
| Study of ARO-DIMERPA in Adult Participants With Mixed Hyperlipidemia (NCT07223658) | Arrowhead Pharmaceuticals | 2025-12-22 |
| Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis (NCT06975787) | Regeneron Pharmaceuticals | 2025-12-22 |
| A Phase 1/2, Open-Label, Single and Multiple Ascending Dose Study of CRMA-1001 in Adults With Chronic Hepatitis B (NCT07200193) | nChroma Bio | 2025-12-22 |
| A Comparative Phase 1 Study to Evaluate the Pharmacokinetic and Safety of QL2302 vs. Tezspire® in Healthy Subjects (NCT07327697) | Qilu Pharmaceutical Co., Ltd. | 2025-12-22 |
| A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With and Without Reduced Liver Function (NCT07269301) | Pfizer | 2025-12-22 |
| A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies (NCT07316907) | YANRU WANG | 2025-12-22 |
| Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells (NCT07148050) | Seattle Children's Hospital | 2025-12-22 |
| A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) (NCT07242469) | Merck Sharp & Dohme LLC | 2025-12-22 |
| A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas (NCT07316920) | YANRU WANG | 2025-12-22 |
| A Study of [18F]LY4214835 in Healthy Volunteers and Participants With Cancer (NCT07258836) | Eli Lilly and Company | 2025-12-22 |
| A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants (NCT07271693) | Hoffmann-La Roche | 2025-12-22 |
| A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients. (NCT07283367) | Hansoh BioMedical R&D Company | 2025-12-22 |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis (NCT07344558) | Mannkind Corporation | 2025-12-22 |
| Ketamine Biomarker Validation (NCT07307768) | Soterix Medical | 2025-12-20 |
| GenSci143 in Participants With Advanced Solid Tumors (NCT07252414) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2025-12-20 |
| The Value of GRPR PET Imaging for Diagnosis and Staging in Prostate Cancer (NCT07363382) | First Affiliated Hospital of Fujian Medical University | 2025-12-20 |
| Lateral Plantar Artery Embolization For Plantar Fasciitis (NCT07395128) | Joint & Vascular Institute | 2025-12-20 |